444 related articles for article (PubMed ID: 21832246)
1. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
2. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
3. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
[TBL] [Abstract][Full Text] [Related]
4. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
[TBL] [Abstract][Full Text] [Related]
5. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
6. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
[TBL] [Abstract][Full Text] [Related]
7. GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes.
Evenson AR; Fareed MU; Menconi MJ; Mitchell JC; Hasselgren PO
Int J Biochem Cell Biol; 2005 Oct; 37(10):2226-38. PubMed ID: 16051512
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
Li BG; Hasselgren PO; Fang CH
Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
[TBL] [Abstract][Full Text] [Related]
9. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
10. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle.
Edström E; Altun M; Hägglund M; Ulfhake B
J Gerontol A Biol Sci Med Sci; 2006 Jul; 61(7):663-74. PubMed ID: 16870627
[TBL] [Abstract][Full Text] [Related]
11. IGF-I activates the mouse type IIb myosin heavy chain gene.
Shanely RA; Zwetsloot KA; Childs TE; Lees SJ; Tsika RW; Booth FW
Am J Physiol Cell Physiol; 2009 Oct; 297(4):C1019-27. PubMed ID: 19657059
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.
van der Velden JL; Langen RC; Kelders MC; Wouters EF; Janssen-Heininger YM; Schols AM
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C453-62. PubMed ID: 16162663
[TBL] [Abstract][Full Text] [Related]
13. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1.
Léger B; Vergani L; Sorarù G; Hespel P; Derave W; Gobelet C; D'Ascenzio C; Angelini C; Russell AP
FASEB J; 2006 Mar; 20(3):583-5. PubMed ID: 16507768
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific GSK-3β ablation accelerates regeneration of disuse-atrophied skeletal muscle.
Pansters NA; Schols AM; Verhees KJ; de Theije CC; Snepvangers FJ; Kelders MC; Ubags ND; Haegens A; Langen RC
Biochim Biophys Acta; 2015 Mar; 1852(3):490-506. PubMed ID: 25496993
[TBL] [Abstract][Full Text] [Related]
15. Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.
van der Velden JL; Langen RC; Kelders MC; Willems J; Wouters EF; Janssen-Heininger YM; Schols AM
Am J Physiol Cell Physiol; 2007 May; 292(5):C1636-44. PubMed ID: 17166938
[TBL] [Abstract][Full Text] [Related]
16. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
[TBL] [Abstract][Full Text] [Related]
17. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
[TBL] [Abstract][Full Text] [Related]
18. Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes.
Eo H; Reed CH; Valentine RJ
Biomed Pharmacother; 2020 Aug; 128():110238. PubMed ID: 32450522
[TBL] [Abstract][Full Text] [Related]
19. Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats.
Yin HN; Chai JK; Yu YM; Shen CA; Wu YQ; Yao YM; Liu H; Liang LM; Tompkins RG; Sheng ZY
J Trauma; 2009 Apr; 66(4):1083-90. PubMed ID: 19359918
[TBL] [Abstract][Full Text] [Related]
20. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle.
Frost RA; Nystrom GJ; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E501-12. PubMed ID: 17003238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]